Study Of Allergic Rhinitis In Patients Who Also Have Asthma
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain
clinic visits will include a physical examination, medical history review, and lung function
tests. All study related medications and medical examinations will be provided at no cost to
the subject. The drugs used in this study are approved for the age group under study.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Montelukast Salmeterol Xinafoate Xhance